Medical News

RSS

Hazelden Betty Ford Foundation, Cerner partner to elevate care of individuals with addiction disorders

The Hazelden Betty Ford Foundation, the nation's largest nonprofit addiction treatment solutions provider, announced today it has selected leading health IT supplier Cerner Corp. to implement a new electronic health record (EHR) system throughout its organization.

4 Mar 2015

Accidental fentanyl exposure in children can be fatal

Infants and children are at a higher risk of accidental exposure to fentanyl patches—adhesive patches used to deliver higher doses of some opiates through the skin to relieve chronic pain.

4 Mar 2015

Bayer announces FDA acceptance of BAY 81-8973 BLA for treatment of hemophilia A

Bayer HealthCare today announced that the U.S. Food and Drug Administration has accepted the company's Biologics License Application for BAY 81-8973, a recombinant Factor VIII compound. Bayer is seeking FDA approval of the investigational compound, proposed trade name Kovaltry, for the treatment of hemophilia A in children and adults.

4 Mar 2015

Kinsa Groups launched to monitor overall health of children in U.S. public schools

Kinsa, the maker of the first FDA approved app-enabled smartphone thermometer, today announced the launch of Kinsa Groups for its iOS and Android apps. The Groups feature is currently available for public schools across the United States. With Kinsa Groups, parents can monitor the overall health at their child's school to better track, treat, and stop the spread of illness at the earliest signs of symptoms.

4 Mar 2015

Surgical science wins ACG minnesota BOLD award

Surgical Science, leading developer of virtual reality surgical simulation training systems, was the recipient of the 2015 Small Corporate BOLD Award from the Association for Corporate Growth (ACG) Minnesota.

4 Mar 2015

Symbiomix Therapeutics announces positive results from SYM-1219 Phase 1 clinical program

Symbiomix Therapeutics, a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women's health infections, today announced results from its Phase 1 clinical program demonstrating that its lead product candidate, SYM-1219, was safe and well tolerated and had predictable pharmacokinetics (PK), and that contraceptive efficacy for birth control pills would not be altered by SYM-1219 administration.

4 Mar 2015

Restore Health Rehabilitation opens modern medical resort in Southern Maryland

Southern Maryland's first modern medical resort officially opened its doors with a ribbon-cutting ceremony on February 27.

4 Mar 2015

IMRIS announces net loss of $6.8 million for fourth quarter 2014

IMRIS Inc. today reported financial results for the fourth quarter and full year ended December 31, 2014. All figures are reported in U.S. dollars. The Company's net loss in the 2014 fourth quarter was $6.8 million, or $0.13 per diluted share, on net revenues of $9.6 million.

4 Mar 2015

Resverlogix, Emerald Logic complete collaborative research program

Resverlogix Corp. today announced that it has completed a collaborative research program with Emerald Logic, a leader in quantitative analytics. Using Fast Collective Evolution Technology (FACET), Emerald Logic analyzed Resverlogix's complete clinical dataset including all measurements obtained from each of 798 patients who participated in the Company's Phase 2 clinical trials ASSERT, SUSTAIN and ASSURE.

4 Mar 2015

Brident Dental celebrates third anniversary with opening of first California office

Brident Dental & Orthodontics celebrated its third anniversary with the opening of its first office in California. The new office located in Riverside, CA marks Brident's twenty-ninth location in the country.

4 Mar 2015

Mayo Clinic, Gentag partner to develop wearable biosensors for treating obesity, diabetes

Mayo Clinic and Gentag, Inc. have reached an agreement to develop the next generation of wearable biosensors designed to fight obesity and diabetes.

4 Mar 2015

PINN partners with Clinicient to strengthen clinical and business decisions

Clinicient Inc., a leader in outpatient rehabilitation business solutions, announced today that People's Injury Network Northwest, a preeminent industrial rehabilitation physical and occupational therapy provider in Washington state, has selected Clinicient's PracticeInsight cloud-based EMR and billing solutions.

4 Mar 2015

New CPPP report shows that one in four Texas children lives in poverty

One in four Texas children lives in poverty, threatening their potential and the state's continued prosperity. According to State of Texas Children 2015, a new Center for Public Policy Priorities (CPPP) report released today, slight improvements in health care and school nutrition don't compensate for inadequate investments in education and child protection.

4 Mar 2015

Reducing premature deaths from noncommunicable diseases: an interview with Dr Shanthi Mendis, WHO

The main types of NCD are cardiovascular disease, cancer, chronic respiratory diseases and diabetes. These have been identified as the principal conditions for three main reasons. One is that, collectively, they contribute the most to the total disease burden.

4 Mar 2015

Study shows strong link between adolescent obesity and high blood pressure

A recent study published in the American Journal of Hypertension has found that body mass index (BMI) in healthy adolescents has a statistically significant association with both systolic blood pressures (SBP) and diastolic blood pressures (DBP), and highlights the significance of the global trend of rapidly increasing adolescent obesity.

4 Mar 2015

Diplomat Pharmacy selected to distribute Novartis' COSENTYX (secukinumab)

Diplomat Pharmacy, Inc. has been selected to the Novartis limited-distribution panel to distribute COSENTYX (secukinumab), a drug approved in January by the U.S. Food and Drug Administration to treat adults with moderate-to-severe plaque psoriasis.

4 Mar 2015

Halyard Health's net sales increase 2% to $439 million in fourth quarter 2014

Halyard Health, Inc. today reported year-end 2014 results and provided its 2015 outlook and related key planning assumptions.

4 Mar 2015

Lexicon updates drug development progress, reports 2014 financial results

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on developing breakthrough treatments for human disease, today updated its drug development progress and reported financial results for the three months and year ended December 31, 2014.

4 Mar 2015

Enrollment completed in Pharma Two B's P2B001 Phase IIb study for Parkinson's disease treatment

Pharma Two B announced today that enrollment has been completed in the company's Phase IIb study of P2B001 for the treatment of early stage Parkinson's disease. One hundred and forty-nine patients enrolled in the study conducted at 29 clinical sites throughout the US and Israel.

4 Mar 2015

CHOP earns Level 2 ACO accreditation

The National Committee for Quality Assurance has announced that The Children's Hospital of Philadelphia has earned accreditation as a Level 2 Accountable Care Organization.

4 Mar 2015

Medical News

Hazelden Betty Ford Foundation, Cerner partner to elevate care of individuals with addiction disorders

Accidental fentanyl exposure in children can be fatal

Bayer announces FDA acceptance of BAY 81-8973 BLA for treatment of hemophilia A

Kinsa Groups launched to monitor overall health of children in U.S. public schools

Surgical science wins ACG minnesota BOLD award

Symbiomix Therapeutics announces positive results from SYM-1219 Phase 1 clinical program

Restore Health Rehabilitation opens modern medical resort in Southern Maryland

IMRIS announces net loss of $6.8 million for fourth quarter 2014

Resverlogix, Emerald Logic complete collaborative research program

Brident Dental celebrates third anniversary with opening of first California office

Mayo Clinic, Gentag partner to develop wearable biosensors for treating obesity, diabetes

PINN partners with Clinicient to strengthen clinical and business decisions

New CPPP report shows that one in four Texas children lives in poverty

Reducing premature deaths from noncommunicable diseases: an interview with Dr Shanthi Mendis, WHO

Study shows strong link between adolescent obesity and high blood pressure

Diplomat Pharmacy selected to distribute Novartis' COSENTYX (secukinumab)

Halyard Health's net sales increase 2% to $439 million in fourth quarter 2014

Lexicon updates drug development progress, reports 2014 financial results

Enrollment completed in Pharma Two B's P2B001 Phase IIb study for Parkinson's disease treatment

CHOP earns Level 2 ACO accreditation

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News